May and Baker Pharmaceuticals Limited
About May and Baker Pharmaceuticals Limited
Data last updated:
May and Baker Pharmaceuticals Limited is a public limited company based in Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U15400DL2006PLC145272. Its GSTIN is 07AAECM5796N1ZO (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Pooja Sharma and Manju Bist.
Its last annual general meeting (AGM) was held on 31 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 303 Mohan Place, L.S.C. C – Block Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹1.22 Cr, a decline of 85% compared to the previous year. For the same year it recorded a net profit of ₹40.1 Lakh (net margin 32.8%) and EBITDA of ₹40.83 Lakh (EBITDA margin 33.4%). Revenue has declined at a compounded annual rate (CAGR) of 68% over three years and 48% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹10 Cr on record. Court records list 27 cases involving the company, including 24 filed by the company and 3 filed against it; 16 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
May and Baker Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231DL2006PLC145272. The current CIN is U15400DL2006PLC145272, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U15400DL2006PLC145272 | Current |
| U24231DL2006PLC145272 | Previous |
Contact details
May and Baker Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address303 Mohan Place, L.S.C. C – Block Saraswati Vihar, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of May and Baker Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of May and Baker Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of May and Baker Pharmaceuticals Limited, buy the company report.
Financials of May and Baker Pharmaceuticals Limited
FY 2026 filings availableMay and Baker Pharmaceuticals Limited reported revenue of ₹1.22 Cr (down 85% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 48% over five years, including a 85% fall in the latest year. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 33.4% | ||||
| Net Profit Margin | 32.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of May and Baker Pharmaceuticals Limited, buy the company report.
Board of directors of May and Baker Pharmaceuticals Limited
May and Baker Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Sharma Also directs: Plenteous Pharmaceuticals Limited | Director | 15 May 2015 | 11 Years 5 Months | Current |
| Manju Bist Also directs: Unosource Pharma Limited, Medibox Pharma Private Limited | Director | 02 Mar 2009 | 17 Years 7 Months | Current |
| Ritu Mirg | Director | 02 Mar 2009 | 17 Years 7 Months | Current |
Auditor
May and Baker Pharmaceuticals Limited is audited by V.P. GUPTA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.P. GUPTA & CO. | FY 2023 | 000699N |
Shareholding
The shareholding of May and Baker Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of May and Baker Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2023 | 100743628 | Hdfc Bank Limited | ₹5 Cr | Satisfied | |
| 19 May 2017 | 100101977 | Yes Bank Limited | ₹5 Cr | Satisfied |
To see the full charge records of May and Baker Pharmaceuticals Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
May and Baker Pharmaceuticals Limited has 27 court cases on record: 24 filed by May and Baker Pharmaceuticals, 3 filed against it. 16 cases are pending and 11 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 2 | 15 |
| High courts | 4 | 1 | 1 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Mankind Pharma Limited & Anr. | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against C P Thakkar and Company (Pharma) Limited | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of May and Baker Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for May and Baker Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
May and Baker Pharmaceuticals Limited has a workforce of 8 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
May and Baker Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECM5796N1ZO | Delhi | Active | 01 Jul 2017 |
| 06AAECM5796N1ZQ | Haryana | Active | 05 Jun 2018 |
To see the full GST registrations and return filing status of May and Baker Pharmaceuticals Limited, buy the company report.
Recent activity
May and Baker Pharmaceuticals Limited has 21 board changes on record since 2006: 12 appointments and 9 cessations. The latest: Anil Kumar Trikha ceased to be Additional Director on 28 Apr 2023.
16 earlier events are in the company report.
Frequently asked questions
May and Baker Pharmaceuticals is an active public limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 January 2006 (20+ years old) and is registered under CIN U15400DL2006PLC145272.
May and Baker Pharmaceuticals has 3 current directors:
- Pooja Sharma - Director
- Manju Bist - Director
- Ritu Mirg - Director
The latest financial statements of May and Baker Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 May 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of May and Baker Pharmaceuticals is 07AAECM5796N1ZO, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAECM5796N1ZQ (Haryana).
The CIN (Corporate Identification Number) of May and Baker Pharmaceuticals is U15400DL2006PLC145272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
May and Baker Pharmaceuticals has 27 court cases on record: 24 filed by the company and 3 filed against it. 16 are pending. Most are in the district courts.
May and Baker Pharmaceuticals was incorporated on 23 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Anil Kumar Trikha ceased to be Additional Director on 28 Apr 2023. Anil Kumar Trikha was appointed as Additional Director on 26 Sep 2022. Rashi Goel ceased to be Director on 27 May 2019. May and Baker Pharmaceuticals has 21 board changes on record in total.
The registered office of May and Baker Pharmaceuticals is at 303 Mohan Place, L.S.C. C – Block Saraswati Vihar, Delhi, India – 110034.
May and Baker Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
